Are you innovating your way through the global pandemic?

10

Min Read

In this blog:

  • We're looking for the most innovative life science companies
  • To enter our Covid-19 Innovation Award
  • Meet our judges for this exciting category!

Here at CiteAb we have been excited to hear about the many ways in which companies across the life science sector have responded to the challenging times posed by COVID-19 by being highly creative and innovative, developing new products, ideas, and ways of working. 

We feel like this year’s awards should recognise the immense effort it takes to be innovative in the face of such adversity, and celebrate the successes that have come as a result of the hard work and novel approaches that many of you have undertaken. 

If you feel that this describes your company or a team in your organisation, then do enter our ‘COVID-19 Innovation Award’. We want to hear about those innovations that have allowed companies to succeed, or to contribute to the success and wellbeing of others, in the face of the global COVID-19 pandemic.

For this category we have recruited four excellent scientists who will make their decision based on the nominee that has had a significant response to COVID-19. This might be in adapting their business, in providing specialist products, or in another manner which is specific to the company’s experiences as a result of the pandemic. The more information you can give our judging panel the better.

Our judges are: 

Robin Padilla, Director of Product Management, Springer Nature Experiments

Robin Padilla is the director of product management for the Springer Nature Experiments platform in Springer Nature’s Data and Analytics Solutions group.

Robin has a PhD in chemistry from the University of California, Berkeley and was a researcher at BASF’s Catalysis Research Laboratory in Heidelberg, Germany. Transitioning to publishing, Robin worked in editorial roles at various publishers before joining Springer Nature’s database product management team. He is currently based in New York City.

Victoria Sherwood, Expert Scientific Writer, Novartis

A former Principle Investigator at the University of Dundee focusing on skin cancer research, Victoria is transitioning into medical communications in the pharmaceutical industry – where she now works for Novartis as an Expert Scientific writer.

Victoria is based in Dublin and also runs a blog hosting site which provides impartial advice for STEM researchers on how to navigate the world of work and build a successful career. 

Momna Hejmadi, Professor of Bioscience Education and Technology, University of Bath

Momna Hejmadi is the Associate Dean for the Faculty of Science and Professor of Bioscience Education and Technology at the University of Bath.

Her research interests focus on cancer biology and she has a long-standing interest in the commercialisation of scientific discoveries.

Momna is currently based in the city of Bath. 

Dr Andrew Chalmers, CEO, CiteAb 

Andrew is a cell biologist who completed his PhD at the University of Bath and postdoctoral work at the University of Cambridge, before returning to Bath to establish his research group which focused on cancerous epithelial cells. He co-founded CiteAb in 2014 while at the University of Bath, before taking a full-time role as CEO in September 2020.

Enter the awards today!

So if your company deserves recognition for its innovation in the face of COVID-19, now is your chance to let us know. Enter our ‘COVID-19 Innovation Award’ category and be in with your chance of winning. 

The CiteAb Awards 2021 are open for entries until midnight (GMT) on Friday 25th February 2021. If you’ve not had a look at this year’s categories, visit our award pages today. Winners will be announced on 21st March 2021. 

– Katrina and the CiteAb team

Join thousands of people who already enjoy the CiteAb newsletter

To keep up to date with the latest developments to our search engine, news from our life science market data analysis and improvements to our citation provision.